A detailed history of Clearline Capital LP transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Clearline Capital LP holds 51,933 shares of ELAN stock, worth $603,980. This represents 0.03% of its overall portfolio holdings.

Number of Shares
51,933
Previous 37,133 39.86%
Holding current value
$603,980
Previous $535,000 42.43%
% of portfolio
0.03%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.85 - $15.47 $175,380 - $228,956
14,800 Added 39.86%
51,933 $762,000
Q2 2024

Aug 14, 2024

SELL
$12.93 - $18.45 $4.57 Million - $6.51 Million
-353,066 Reduced 90.48%
37,133 $535,000
Q1 2024

May 15, 2024

SELL
$14.37 - $16.46 $3.76 Million - $4.31 Million
-261,773 Reduced 40.15%
390,199 $6.35 Million
Q4 2023

Feb 14, 2024

SELL
$8.6 - $14.94 $6.77 Million - $11.8 Million
-786,793 Reduced 54.69%
651,972 $9.71 Million
Q2 2023

Aug 14, 2023

BUY
$8.08 - $10.37 $4.92 Million - $6.31 Million
608,529 Added 73.3%
1,438,765 $14.5 Million
Q1 2023

May 15, 2023

BUY
$8.79 - $14.58 $2.16 Million - $3.59 Million
246,112 Added 42.13%
830,236 $7.8 Million
Q4 2022

Feb 14, 2023

SELL
$11.49 - $13.65 $374,102 - $444,430
-32,559 Reduced 5.28%
584,124 $7.14 Million
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $1.56 Million - $4.06 Million
125,384 Added 25.52%
616,683 $7.65 Million
Q1 2022

May 16, 2022

BUY
$24.65 - $29.0 $2.08 Million - $2.45 Million
84,382 Added 20.74%
491,299 $12.8 Million
Q4 2021

Feb 14, 2022

SELL
$27.74 - $34.09 $1.02 Million - $1.25 Million
-36,600 Reduced 8.25%
406,917 $11.5 Million
Q3 2021

Nov 15, 2021

BUY
$29.2 - $36.72 $8.15 Million - $10.3 Million
279,255 Added 170.01%
443,517 $14.1 Million
Q2 2021

Aug 16, 2021

SELL
$28.76 - $35.98 $347,794 - $435,106
-12,093 Reduced 6.86%
164,262 $5.7 Million
Q1 2021

May 17, 2021

BUY
$27.85 - $34.49 $4.91 Million - $6.08 Million
176,355 New
176,355 $5.19 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.51B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.